47 related articles for article (PubMed ID: 35311064)
1. Acute Findings on FDG PET/CT: Key Imaging Features and How to Differentiate Them from Malignancy.
Li Y; Behr S
Curr Radiol Rep; 2020; 8(11):22. PubMed ID: 32953250
[TBL] [Abstract][Full Text] [Related]
2. Advanced imaging shows extra-articular abscesses in two out of three adult patients with septic arthritis of the native hip joint.
Cools J; Ghijselings S; Ruythooren F; Jentjens S; Noppe N; Metsemakers WJ; Vles G
J Bone Jt Infect; 2024; 9(1):27-35. PubMed ID: 38601001
[No Abstract] [Full Text] [Related]
3. Metabolic and molecular imaging in inflammatory arthritis.
Noversa de Sousa R; Tascilar K; Corte G; Atzinger A; Minopoulou I; Ohrndorf S; Waldner M; Schmidkonz C; Kuwert T; Knieling F; Kleyer A; Ramming A; Schett G; Simon D; Fagni F
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38341194
[TBL] [Abstract][Full Text] [Related]
4. Indications for diagnostic use of nuclear medicine in rheumatology: A mini-review.
Wenger M; Schirmer M
Front Med (Lausanne); 2022; 9():1026060. PubMed ID: 36250088
[TBL] [Abstract][Full Text] [Related]
5. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
6. Whole-Body
Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
[TBL] [Abstract][Full Text] [Related]
7. Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit.
Ulijn E; den Broeder AA; Boers N; Gotthardt M; Bouman CAM; Landewé R; den Broeder N; van Herwaarden N
Rheumatol Adv Pract; 2022; 6(1):rkac014. PubMed ID: 35311064
[TBL] [Abstract][Full Text] [Related]
8. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.
Vijayant V; Sarma M; Aurangabadkar H; Bichile L; Basu S
World J Radiol; 2012 Dec; 4(12):462-8. PubMed ID: 23320137
[TBL] [Abstract][Full Text] [Related]
9. Benefits and harms of implementing [
Vogsen M; Jensen JD; Gerke O; Jylling AMB; Asmussen JT; Christensen IY; Braad PE; Thye-Rønn P; Søe KL; Ewertz M; Hildebrandt MG
EJNMMI Res; 2021 Sep; 11(1):93. PubMed ID: 34553294
[TBL] [Abstract][Full Text] [Related]
10. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value.
Bouman CAM; van Herwaarden N; Blanken AB; Van der Laken CJ; Gotthardt M; Oyen WJG; den Broeder AA; van der Maas A; van den Ende CH
Rheumatology (Oxford); 2022 Apr; 61(SI):SI6-SI13. PubMed ID: 34791068
[TBL] [Abstract][Full Text] [Related]
14. Ten-year prospective evaluation of whole-body cancer screening with multiple modalities including [
Nishizawa S; Kojima S; Okada H; Shinke T; Torizuka T; Teramukai S; Fukushima M
Ann Nucl Med; 2020 May; 34(5):358-368. PubMed ID: 32200511
[TBL] [Abstract][Full Text] [Related]
15. Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULAR.
Mandl P; Ciechomska A; Terslev L; Baraliakos X; Conaghan PG; D'Agostino MA; Iagnocco A; van der Laken CJ; Ostergaard M; Naredo E
RMD Open; 2019; 5(2):e000950. PubMed ID: 31321076
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
